The role of Clopidogrel in the secondary prevention of recurrent ischemic vascular events after acute myocardial ischemia: a critical appraisal of the CURE trial
By: Canadian Coordinating Office for Health Technology Assessment
Publisher: Canadian Coordinating Office for Health Technology Assessment
Place of publication: Ottawa
Number of pages: 28
Subjects: Myocardial ischemia -- complications; Ticlopidine -- therapeutic use
Notes: "November 2002" Technology Report

2